We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Provexis Plc | LSE:PXS | London | Ordinary Share | GB00B0923P27 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.60 | 0.55 | 0.65 | - | 1,516,438 | 09:34:30 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Food Preparations, Nec | 390k | -385k | -0.0002 | -30.00 | 13.31M |
Date | Subject | Author | Discuss |
---|---|---|---|
06/10/2016 14:05 | Although it'll have been down as a "Special" resolution it means nothing that mate, passed at almost all AGMs for most companies. It's just a mechanism to allow companies to buy shares to either cancel or put in treasury. It's a cut and paste job from at least back in 2009 and, so far as I can remember, has never been used BY PXS | bareknee | |
06/10/2016 13:20 | I can see this going to 0.75p or so pretty quickly. Although it wasn't commented on, I remember that one of the resolutions passed was for PXS to buy back 5% of shareholdings. I didn't know what this meant at the time, and still don't. Any thoughts Bernie? | librag | |
06/10/2016 12:51 | Is that 2.2 million sell at 11:48 ( 6th Oct ) yours then Wheel DS ? Nice quick profit for you if it was. BB | bareknee | |
05/10/2016 15:23 | The fact that today the bid price is 0.44p and some are getting 0.45p shows clearly that market expectations are improving for our Fruitflow products.IMHO However, I still believe DSM will eventually buy us out. | wheelds | |
03/10/2016 15:54 | Well put Bernie, thanks. | librag | |
03/10/2016 15:41 | Lafin Shareholders groups can serve a purpose, but that purpose is limited. A few things come to mind. 1. Ian Ford's renumeration increased to £88,002 from £76,251 last FY, that's a rise of 15%. In an environment where, to quote from the report "...and the Group’s cost base and its resources continue to be very tightly managed.", it's hard to justify a 15% pay increase. There might be a very good reason for that increase, but a SAG representing ( say ) 20% of the shareholding is in a much better place to question such a rise. Now from the few dealings I've had with him, I like Ian, he seems competent and honest, but he could be replaced fairly easily if need be so I can't see a need to reward him for retention purposes. If he increased the hours he worked for the company last FY, then that's fair enough. 2. Our new product has been launched and "is expected to provide the Company with an additional income and profit stream", but there's no indication of what the targets are for revenue and profit. A SAG could put pressure on the BoD to release ( via RNS ) what those targets are so the BoD could be judged against those targets 3. Given we now have our own product, a SAG could also put pressure on the board to release quarterly sales figures by RNS so we can judge how things are going compared to both the plan and any marketing initiatives. What a SAG can't really effectively do is change the high level functions of the company. To do that, you'd need enough votes to either change the BoD ( well, Dawson really, he's presumably the one driving things ), or at least have enough votes to make life uncomfortable for them. BB | bareknee | |
03/10/2016 10:32 | lafin; It certainly was theatrical. You couldn't have made it up ... DB couldn't read his script and mentioned thousands instead of millions, on more than one occasion. You may well be right re. SAG. For those of us with relatively large shareholdings, I simply don't understand passivity. | librag | |
02/10/2016 18:19 | Sounds like the whole thing was a piece of theatre. I doubt there is anything a shareholders action group could do though,other than lead to more frustration ,unfortunately. | lafin | |
02/10/2016 16:33 | Graham My guess, based on the wording of the RNS, is that the costs of the roundtable would be split between DSM and ourselves based on how much it was agreed it was a marketing exercise for Fruitflow and how much it was for FF+. Wet finger in the air, I'd guess DSM would have stumped up roughly 75% of the costs, partly because it will benefit Fruitflow as a whole and partly as a goodwill gesture. | bareknee | |
02/10/2016 12:20 | Bernie, I appreciate your position. re. FF+ roundtable. Two thoughts ... - I got the impression (happy to be corrected?) from the AGM that DSM were paying for FF/FF+ promotion as per the KOL round table. - Of course some media Doctors will be happy to promote ... for a fee of course. Others seem more altruistic. The PR and marketing girls talked about FF+ and FF synonymously. | librag | |
01/10/2016 13:41 | Graham Thanks for that. So, in a nutshell ... It sounds like the BoD and DSM waffled a lot without saying much and the scientists are in a bit of a bubble world ? Sadly that's pretty much par for the course. I'll give it till the next set of figures come out and take it from there. 900k shares are worth about 4k so, even in my measley portfolio it's barely worth worrying about BB | bareknee | |
29/9/2016 10:31 | However, there are numerous fruitloops on the OXB threads ... always a worry. | librag | |
29/9/2016 10:14 | Hi SS, I've looked more into OXB. Not an expert by any means but gene therapy looks to have an exciting future. Lentivirus vectors worry me though. It's a gut reaction rather than anything particularly insightful. Last time (AGL) I waited a while and I'll do the same here. ?2.6p but will be tempted at 3p. Let's see and GL to you. | librag | |
28/9/2016 20:42 | Libra, that's what I thought regards TA, etc, but I have had a tip on these for a multibag and the source gives out tips once in a blue moon and usually gets it right, directors are buying in so might have a few k punt. edit, looking at their Careers page looks like they are recruiting too, hxxp://www.oxfordbio | senor_sensible | |
28/9/2016 09:47 | Hi SS, doesn't look good does it? Might be tempted at 3p but not sure. Medically, I don't have a clue about them. TA wise horrendous and as for the BoD .... GL :) | librag | |
27/9/2016 11:31 | Libra, any views on OXB.LS ? | senor_sensible | |
22/9/2016 20:05 | Graham I'm tea-total mate ( that may be a lie ). Southern'll probably be on strike, and surely you get refeshments at the AGM ? The only ones I've ever been to have generally put on a decent spread. | bareknee | |
22/9/2016 19:20 | Hi Bernie, "cuppa"? Nah, I'll suffer SouthernRail. C2H5OH will help. Cheers, | librag | |
20/9/2016 14:18 | Bernie, You going to the meeting? re. nonsense. If one needs regular cover, say for car insurance, one would get it annually. I suppose the health equivalent of regular cover, say BUPA, would also be annual. There are always Herberts who pay monthly, at extra cost for their car insurance and might it be possible that those same Herberts believe month by month sales are meaningful. Apologies to anyone called Herbert. :) | librag | |
07/9/2016 17:24 | Just had a quick skim through the results and I don't think there's anything of any interest which wasn't in the trading update. The only thing worth noting is that info on the BP trial / results MIGHT be available in Q4, so we're talking 2017 now. Though we might not have been told as much, we already knew we'd make another loss this FY and will need more funds. I see they ( esp Ford ) have given themselves a pay rise, which though not surprising is a tad disappointing. Looks like we'll have to wait and see if there's an AGM statement. If there is, then an indication of sales of FF+ and cash in bank would be nice. I ain't holding my breath though. BB | bareknee | |
07/9/2016 11:34 | Hi SS; re. topups. I was in and out on this last rise for 30%'ish. Only a topup sadly but got a healthy profit. Will the share price pullback or will the market see the near potential? I don't think the share price will fall back much, and if it does the spread will undoubtedly be horrendous. Having said that, low 0.4s and low to mid 0.3s will be get me tempted again. The results were pretty boring but do show good improvement I think; awaiting Bernie's view with bated breath. R&D-wise, nothing new and good results are likely re. BP. Whatever happened to the memory trial? ... I forget ... | librag | |
07/9/2016 08:25 | Was expecting better, glad i didn't top up. | senor_sensible | |
06/9/2016 07:19 | What ever happens I am sure it won't happen too quickly otherwise the recent placing will be questioned with regard to insider trading. Still holding the few shares I have got but not risking a top up until I am sure this rise is justified at this moment in time, good luck. | senor_sensible |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions